PIN23 COST-EFFECTIVENESS ANALYSIS OF THE IMPLEMENTATION OF A QUADRIVALENT (6,1 1, 16,18 TYPES) HUMAN PAPILLOMAVIRUS VACCINE TO THE EXISTING BELGIAN CERVICAL CANCER SCREENING PROGRAMME
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65530-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)65530-1/fulltext
Section Title :
Section Order :
689
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65530-1&doi=10.1016/S1098-3015(10)65530-1